Editor's Note

Developing the Active Ingredient

With the increasing incidence of chronic diseases and growing importance of generics, the Active Pharmaceutical Ingredient (API) market is on a path of continuous growth. New technology adoption such as AI-based tools for drug discovery is further fueling the progress of the market. In this special issue, we have focused on this segment. The cover story of this issue features Kimia Biosciences which has carved a niche for itself in devising demand-driven APIs, intermediaries and formulations. In order to provide newer, more innovative, but reasonably priced products across all...  >>More